Jump to Main Content

Programs

Special Interest Sessions

These smaller sessions provide the opportunity for ASH’s various communities to focus on specific topics of interest, ranging from coping with physician stress and burnout, to counseling fellows on careers in hematology, to the impact of ASH’s international outreach programs.

ASH Guidelines on AML in Older Adults: Monitoring Emerging Evidence

During this special education session, presenters will discuss ASH guidelines, which are developed by leading clinical, methodological, and patient experts through a rigorous process to review evidence and write actionable recommendations. 

Chair:

Mikkael A. Sekeres, MD
University of Miami, Sylvester Comprehensive Cancer Center
Miami, FL

Speakers:

Laura C. Michaelis, MD
The Medical College of Wisconsin Inc.
Milwaukee, WI
Monitoring and Updating of the ASH AML Guidelines

Mark R. Litzow, MD
Mayo Clinic
Rochester, MN
Updates on Induction Therapy for Older Adults with AML

Kristen Marie O'Dwyer, MD
University of Rochester Medical Center
Rochester, NY
Updates on Post-Remission Therapy for Older Adults with AML

back to top

ASH Choosing Wisely® Campaign: 2022 ASH Choosing Wisely Champions

In cooperation with the ABIM Foundation, ASH has introduced the Choosing Wisely Champions initiative to recognize the efforts of practitioners who are working to eliminate costly and potentially harmful overuse of tests and procedures. Each year, three individuals are invited to present on successful utilization strategies that they have developed and implemented in their practice, institution, or hospital system. This provides an opportunity for clinicians, administrators, and other medical professionals to learn about projects that might be translated to their own practices.

Chair:

Marc S Zumberg, MD
University of Florida
[email protected], Gainesville, FL

Speakers:

Julia Fortier, MD
University of Florida
Gainesville, FL
Reducing Unnecessary Pre-Medication Prior to Parenteral Iron Therapy

Daanish Hoda, MD
LDS Hospital
Salt Lake City, UT
Reducing Overtesting and Overdiagnosis of Clostrdioides Dificile Infection in the Setting of an HSCT Unit

Kamal K Sahu, MD, DM
University of Utah
Salk Lake City, UT
Implementation of New Electronic Medical Record Algorithm to Streamline the Appropriate Use of Rasburicase

back to top

ASH Guideline Implementation Champions

Moderator:

Rachel P. Rosovsky, MD, MPH
Harvard Medical School
Boston, MA

Speaker:

Jori E. May, MD
University of Alabama at Birmingham
Birmingham, AL
ASH Guideline Implementation Project

back to top

ASH Guidelines on VTE: Prevention and Treatment in Patients with Cancer

During this special education session, presenters will discuss ASH guidelines, which are developed by leading clinical, methodological, and patient experts through a rigorous process to review evidence and write actionable recommendations. 

Chair:

Marc Carrier, MD, MSc, FRCPC
University of Ottawa
Ottawa, ON, Canada

Speakers:

Marc Carrier, MD, MSc, FRCPC
University of Ottawa
Ottawa, ON, Canada
Risk Assessment and Prophylaxis

Radhika Gangaraju, MD
University Of Alabama
Birmingham, AL
Treatment and Secondary Prevention

back to top

ASH Guidelines on VWD: Impact on Patients, Policy, and Allied Health Professionals

During this special education session, presenters will discuss ASH guidelines, which are developed by leading clinical, methodological, and patient experts through a rigorous process to review evidence and write actionable recommendations. 

Chair:

Nathan T. Connell, MD
Brigham and Women's Hospital
Boston, MA

Speakers:

Jean M. Grow, PhD
Marquette University
Milwaukee, WI
Impact of the VWD Guidelines on Patients

Len A. Valentino, MD
National Hemophilia Foundation - - New York, NY
New York, NY
Impact of the VWD Guidelines on the Legislative and Policy Agendas

Penni Jo Smith, MPA, BSN, RN-BC
Primary Children's Hospital
Salt Lake City, UT
Impact of the VWD Guidelines on Allied Health Professionals

back to top

ASH Health Equity Rounds Lunch

Health Equity Rounds are interactive, case-based discussions with an interdisciplinary panel to include hematologists, health equity/public health experts, patients, and patient advocates to discuss health equity issues within hematology. Lunch will be provided to in-person attendees.

Moderator:

Jacquelyn M. Powers, MD, MSc
Texas Children's Hospital
Houston, TX

Speaker:

Angela C. Weyand, MD
University of Michigan
Ann Arbor, MI
Gender Disparities in Bleeding Disorders

back to top

ASH Practice Partnership Lunch - A Return to the Classics: The Need for Classical Hematology

Classical hematologists treat conditions such as iron deficiency anemia, and they are expert at identifying and managing life-threatening conditions such as cold agglutinin disease, thrombotic thrombocytopenic purpura, acquired hemophilia, and heparin-induced thrombocytopenia. Systems-based classical hematologists work within a hospital or health care system on issues such as improving anticoagulation management and peri-operative patient blood management. classical hematology is one of the cognitive fields that does not generate revenue by giving chemotherapy or performing procedures. For this reason, classical hematologists face lower reimbursement than their counterparts practicing malignant hematology or oncology. They see fewer trainees interested in joining their ranks, likely due to the lower reimbursement and the low number of fellowship programs or placement opportunities - something ASH is currently working to address through its new Hematology-Focused Fellowship Training Program. And because there are fewer people entering this field, wait times for an appointment are often long, making it difficult for patients to access timely care.

 

In this session, panelists will explore solutions to the lack of classical hematologists, focusing on three main topics: How to do classical hematology without a hematologist, compensation models in classical hematology, and how to get young hematologists interested in classical hematology.

Chair:

Chancellor E Donald, MD
Tulane University School of Medicine
New Orleans, LA

Speakers:

Janice W. Lawson, MD
Tallahassee Memorial Hospital
Tallahassee, FL
How to Do Classical Hematology Without a Hematologist

David Garcia
University of Washington
Seattle, WA
Justifying the Value of Classical Hematology

Alfred I Lee, MD,PhD
Yale University
New Haven, CT
Getting Young Hematologists Interested in Classical Hematology

back to top

ASH-FDA Joint Symposium on Newly Approved Drugs I

back to top

ASH-FDA Joint Symposium on Newly Approved Drugs II

back to top

Blood and Beyond

At the ASH annual meeting each December, the science of blood, health, and disease brings together more than 30,000 hematologists from around the world for a vigorous discussion and exchange of ideas. The editors of the Blood journal take this opportunity to highlight the intersection of hematology and the humanities in bringing to light the epic story of blood. Past presenters have included Lawrence Hill, the author of Blood: The Stuff of Life, Douglas Starr the author of Blood: An Epic History of Medicine and Commerce, Tom Brokaw, the former NBC News anchor and author of A Lucky Life Interrupted. and most recently, the late Paul Farmer, Kolokotrones University Professor and the chair of the Department of Global Health and Social Medicine at Harvard Medical School whose session: Irrigating the Clinical Desert: Lessons from Haiti and Rwanda is freely available on the ASH website in tribute to his contributions to humanity and medicine.

John M. Barry has had considerable influence on both pandemic policy and flood protection. Both the Bush and Obama administrations sought his advice on influenza preparedness and response, and he was a member of the original team which developed plans for non-pharmaceutical interventions to mitigate a pandemic. Barry has served on advisory boards at M.I.T’s Center for Engineering Systems Fundamentals and the Johns Hopkins Bloomberg School of Public Health as well as on the board of the Society of American Historians. John M. Barry is Distinguished Scholar at both the Tulane University School of Public Health and Tropical Medicine and Tulane's Bywater Institute. Barry concludes in The Great Influenza that "The final lesson of 1918, a simple one yet one most difficult to execute, is that...those in authority must retain the public's trust. The way to do that is to distort nothing, to put the best face on nothing, to try to manipulate no one. Lincoln said that first, and best. A leader must make whatever horror exists concrete. Only then will people be able to break it apart." John M. Barry will address the pandemic of the past as well as the present in context of the history of American medicine.

back to top

Disability Community Networking Breakfast (for in-person participants)

This breakfast is an informal community-building and networking event for members of the disability community attending the meeting. The event is hosted by the ASH Diversity, Equity, and Inclusion (DEI) Programs Subcommittee and aims to create a sense of belonging and allyship and, where possible, identify opportunities to learn more about the experiences and needs of the community to allow us to have a greater impact in our DEI efforts.

back to top

Driving Real-World Evidence for Hematologic Malignancy Research – A Joint ASH RC and EU HARMONY Session

back to top

Grassroots Network Lunch

Thanks to ASH’s advocacy efforts and the ASH Grassroots Network, issues important to the future of hematology have been brought to the attention of the U.S. Congress and federal agencies. The ASH Grassroots Network Lunch provides a forum for interested members to learn how they can participate in ASH’s advocacy efforts, communicate with Congress, become effective advocates for hematology, and discuss the Society’s legislative and regulatory priorities. An overview of the Society’s 2022 advocacy accomplishments and a preview of the Society’s 2023 advocacy agenda, as well as a discussion about the potential impact of the 2022 midterm elections on policy related to hematology, will also be provided.

Chair:

Jennifer Holter Chakrabarty, MD
University of Oklahoma Health Sciences Center
Oklahoma City, OK

back to top

LGBTQIA+ Community Networking Brunch (for in-person participants)

This brunch is an informal community-building and networking event for members of the LGBTQIA+ community attending the meeting. The event is hosted by the ASH Diversity, Equity, and Inclusion (DEI) Programs Subcommittee and aims to create a sense of belonging and allyship and, where possible, identify opportunities to learn more about the experiences and needs of the community to allow us to have a greater impact in our DEI efforts.

back to top

Maternal Health in Hematology - Current Resources and Future Advocacy

Moderator:

Sarah H. O'Brien, MD
Nationwide Children's Hospital
Columbus, OH

Speakers:

Mikkael A. Sekeres, MD
University of Miami, Sylvester Comprehensive Cancer Center
Miami, FL
Op-ed: a Washington Post Study

Deva Sharma, MD
Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease
Nashville, TN
Grassroots Advocacy: a Tennessee Study

back to top

Medical Educators’ Symposium

The Medical Educators Symposium (previously called the Hematology Course Directors Workshop) is open to all medical educators across the medical student, resident, and fellow continuum. The Medical Educators Symposium highlights cutting edge teaching techniques and theories while also showcasing participants of the ASH Medical Educators Institute. The symposium is two hours long and will begin with a general session focused on medical education principles.

Chair:

Sanjay R Mohan, MD, MSCI
Vanderbilt-Ingram Cancer Center
Nashville, TN

Speakers:

Alfred I Lee, MD,PhD
Yale University School of Medicine
New Haven, CT
Burnout and Faculty Engagement

Rakesh P. Mehta, MD
Indiana University School of Medicine
Indianapolis, IN
Breakout Session: How to Write a Good Letter of Recommendation 

back to top

Promoting Minorities in Hematology Oral Presentations Room I

ASH invites all interested meeting attendees to this event, which will showcase training and research opportunities geared toward increasing the diversity of scholars in the field of hematology. The highlight of the session will be scientific presentations from the ASH Minority Medical Student Award, the ASH Minority Resident Hematology Award, the ASH Minority Hematology Graduate Award, and the ASH Minority Hematology Fellowship Award program participants. A reception will follow the presentations.

back to top

Promoting Minorities in Hematology Oral Presentations Room II

ASH invites all interested meeting attendees to this event, which will showcase training and research opportunities geared toward increasing the diversity of scholars in the field of hematology. The highlight of the session will be scientific presentations from the ASH Minority Medical Student Award, the ASH Minority Resident Hematology Award, the ASH Minority Hematology Graduate Award, and the ASH Minority Hematology Fellowship Award program participants. A reception will follow the presentations.

back to top

Promoting Minorities in Hematology Oral Presentations Room III

ASH invites all interested meeting attendees to this event, which will showcase training and research opportunities geared toward increasing the diversity of scholars in the field of hematology. The highlight of the session will be scientific presentations from the ASH Minority Medical Student Award, the ASH Minority Resident Hematology Award, the ASH Minority Hematology Graduate Award, and the ASH Minority Hematology Fellowship Award program participants. A reception will follow the presentations.

back to top

Promoting Minorities in Hematology Reception

ASH invites all interested meeting attendees to attend the Promoting Minorites in Hematology reception following oral presentations by award recipients of the ASH Minority Recruitment Initiative (MRI) Awards Pathway.

back to top

Special Interest Session on Sickle Cell Disease Centers: Ensuring Appropriate Care Across the Patient Lifespan

back to top

Special Session: AI and Machine Learning: A New Frontier in Hematology

Artificial intelligence (AI) and related technologies are increasingly established in business, society, and beginning to be applied in healthcare. These technologies have the potential to transform research and patient care in hematology from diagnosis to prognosis and treatment selection. This session will highlight the current application of AI and machine learning (ML) in diagnostic hematology and clinical research. It will also discuss the current challenges in explaining AI and regulatory approvals of AI algorithms in healthcare. 

Dr. Nazha will discuss the basics and the differences between AI, ML, and deep learning (DL). He will review the forces that drive the excitement about AI in healthcare and why AI could be valuable in advancing research in the medical field. He will also dive deep into the mechanics of how ML and DL algorithms work and the optimal ways to use them in medicine. Finally, Dr. Nazha will discuss some of the use cases and novel advances in ML and DL in real life and medicine.

Dr. Olivier Elemento will discuss some of the recent applications of ML in diagnostic hematology. He will address the strengths and weaknesses of these methods including accuracy and biases, the extent of their current clinical use, and potential barriers to broader implementation and clinical application. Dr. Elemento will also outline future potential applications based on recent developments in the field of ML and newly available datasets.

Dr. Ilana Goldberg will discuss the current trends to incorporate AI and ML into healthcare diagnostics and treatments. She will discuss how these technology tools are being introduced in the field of hematology and possibilities for how they can continue to be developed for blood diseases.

Dr. Shannon McWeeney will review the process of transitioning ML algorithms and models from research to the clinic which include validation, bias assessment, hardening, and deployment. She will highlight current challenges in clinical data in the EHR for both model development and deployment. Dr. McWeeney will also discuss the governance, regulatory, and oversight considerations for AI/ML-based software at institutional and federal levels. Lastly, she will examine what is needed to ensure actionable decision support regarding transparency and explaining these technologies.

Chair:

Aziz Nazha, MD
Thomas Jefferson University
Cherry Hill, NJ

Speakers:

Aziz Nazha, MD
Incyte
Westlake, OH
AI 101: Why is AI and Machine Learning Important in Hematology?

Olivier Elemento, PhD
Weill Cornell Medicine
New York, NY
The Application of Machine Learning in Diagnostic Hematology

Ilana Goldberg, PhD
National Institute of Health
Bethesda, MD
AI in the Clinic: The Current Translation of Machine Learning Algorithms into Clinical Decision Tools

Shannon K. McWeeney
OHSU
Portland, OR
AI Challenges in Regulatory Approvals and Explicability

back to top

Special Session: Building a Nationwide Sickle Cell Disease Data Hub and Learning Community

back to top

Special Symposium on Quality: Quality Improvement Education and Training

During this special education session, presenters will discuss ASH guidelines, which are developed by leading clinical, methodological, and patient experts through a rigorous process to review evidence and write actionable recommendations.

Chair:

Michael Keng, MD
UVA Health
Charlottesville, VA

Speakers:

Jose Azar, MD
Indiana University Simon Cancer Center
Indianapolis, IN
Quality Improvement Overview

Ashley E. Rosko, MD
The Ohio State University
Columbus, OH
Quality Improvement Project, Implementing Age-Friendly practices in Older Adults with Hematologic Malignancies

Rachael F. Grace, MD
Children's Hospital Boston
Boston, MA
Quality Improvement Project, Immune Thrombocytopenia (ITP)

back to top

Systems-Based Hematology Education and Networking Session

The first hour focuses on Systems-Based approaches and Systems-Level interventions in hematologic care. The second hour transitions to networking amongst peers with drinks and hors d'oeuvres.

Chair:

Marc S Zumberg, MD
University of Florida
[email protected], Gainesville, FL

Speakers:

MIchael B. Streiff, MD
Johns Hopkins Medical Institutions
Baltimore, MD
A Systems-Based Approach to the Prevention and Management of Cancer-Associated Thrombosis

Annette S. Kim, MD,PhD
Brigham and Women's Hospital
Boston, MA
Avoiding Overuse of Molecular/Genetic Testing Via Systems-Level Interventions

back to top

Training Program Directors' Workshop

The Training Program Directors Workshop is held each year before the ASH annual meeting and is designed for training program directors, associate program directors, and others involved with hematology training to share lessons learned, best practices, and explore opportunities to improve their leadership skills. Through experiential learning techniques, breakout sessions, and interactive lectures, program directors can learn from peers and build their network.

Chair:

Alfred I Lee, MD,PhD
Yale University School of Medicine
New Haven, CT

Speakers:

Alan E. Mast, MD, PhD
Blood Center of Wisconsin
Milwaukee, WI
Diversity, Equity, and Inclusion

Cecelia Calhoun, MD,MBA,MPH
Yale University
New Haven, CT
Diversity, Equity, and Inclusion

Soo Park, MD
University of California San Diego
San Diego, CA
Mentorship and Career Development

Valentina Baez Sosa, MD
MedStar Washington Hospital
Washington, DC
How the Personal Characteristics of Grit and Resilience Relate to Physician Well-Being  

Leslie Renee Ellis, MD
Comprehensive Cancer Center of Wake Forest Baptist Health
Winston-Salem, NC
How the Personal Characteristics of Grit and Resilience Relate to Physician Well